Glutamate Carboxypeptidase 2 Market by Major Companies Involved in Therapeutics Development, 2018-2022

Glutamate Carboxypeptidase 2

Overview

Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) - Glutamate carboxypeptidase II (GCPII) is a membrane-bound binuclear zinc metallopeptidase with the highly expressed in nervous and prostatic tissue.

Glutamate carboxypeptidase II (GCPII) is an enzyme encoded by the FOLH1 (folate hydrolase 1) gene. GCPII is intimately involved in the neuron-neuron and neuron-glia signaling via the hydrolysis of N-acetylaspartylglutamate (NAAG). The inhibition of the GCPII-controlled NAAG catabolism has been shown to plat important role in traumatic brain injury, stroke, neuropathic and inflammatory pain, amyotrophic lateral sclerosis, schizophrenia and prostate carcinoma.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3031114-glutamate-carboxypeptidase-2-folate-hydrolase-1-or-prostate

 

Major Key Players:

Crescendo Biologics Ltd

Eisai Co Ltd

Inovio Pharmaceuticals Inc

Glutamate Carboxypeptidase 2 Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Glutamate Carboxypeptidase 2    - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Glutamate Carboxypeptidase 2   , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase II, Phase I and Preclinical stages are 1, 1 and 2 respectively.

Glutamate Carboxypeptidase 2 pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Glutamate Carboxypeptidase 2 - Competitive Analysis

Key players are making innovative developments in Glutamate Carboxypeptidase 2 industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Glutamate Carboxypeptidase 2.

The pipeline guide reviews pipeline therapeutics for Glutamate Carboxypeptidase 2 by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Glutamate Carboxypeptidase 2 therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Glutamate Carboxypeptidase 2 therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Glutamate Carboxypeptidase 2.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3031114-glutamate-carboxypeptidase-2-folate-hydrolase-1-or-prostate

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.